The Landscape of GLP-1 Prescriptions in Germany: A Comprehensive GuideThe pharmaceutical landscape in Germany has actually undergone a significant shift over the last two years, driven largely by the worldwide rise in need for GLP-1 (Glucagon-like peptide-1) receptor agonists. Initially developed to treat Type 2 diabetes, these medications have actually
